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Glucose 6-phosphate dehydrogenase (G6PD) was induced from 
the livers of male and female castrated and intact rats by estradiol 
and testosterone. This study provided information on the activity of 
G6PD and sex differential expression of the enzyme. G6PD from the 
laying hen was purified to 3000-4000 fold and 60-70 Units/mg 
protein of enzyme activity. The characteristics of the purified 
enzyme were compared to those of the immature chicken at different 
ages (1-12 wk-old). Isozyme studies showed that the electrophoretic 
patterns of the enzyme from immature chicken (1-12 wk-olds) and 
adult male chicken are similar, but differ from that of the laying hen. 
In the immature chicken, the composition of the isozymes ranged 
from 4-9 (Band A), 25-33 (Band B) and 54-66 % (Band C). The 
values for the laying chicken were 54 (Band A), 27 (Band B) and 16 
% (Band C). Enzyme activity (Units/mg protein) was significantly 
lower in adult male and the 1 week-old female chicken (0.01 ± 
0.001) and higher in the laying (0.019 ± 0.002) and the 12 week-old 
female chicken (0.022 ± 0.003). The enzyme is a dimer with 
molecular weight estimated at 130,000 on gel filtration and the 
subunit monomer 65,000 on SDS-PAGE. The differences in the 
activity and isozyme patterns of chicken liver G6PD appear to be 
regulated by sex steroid hormones. 
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Glucose 6-phosphate dehydrogenase (G6PD) catalyzes the 
conversion of glucose 6-phosphate (G6P) to gluconolactone 6- 
phosphate in the presence of nicotinamide adenine dinucleotide 
phosphate (NADP) and to a lesser extent, nicotinamide adenine 
dinucleotide (NAD). G6PD is the first enzyme in the pentose 
monophosphate shunt pathway (PMSP) which generates the bulk of 
reduced pyridine nucleotides (NADPH) and ribose-5-phosphate. 
These nucleotides and phosphates are used for the biosynthesis of 
nucleic acids, fatty acids and steroids as well as for the maintenance 
of viable erythrocytes (Keller, 1971; Eaton and Brewer, 1974). The 
enzyme has been isolated, purified and characterized in several 
sources including microbial organisms (Olive and Levy, 1967), 
plants (Muto and Uritani, 1970, Kickenscher and Scheibe, 1986), 
mouse (Hizi and Yagil, 1976), rats (Matsuda and Yugari, 1966), 
bovine (Singh and Squire, 1975) and in humans (Shrieve and Levy, 
1977). However, in some tissues the role of G6PD is not well 
defined. For example in bacteria, the Entner-Doudoroff pathway 
(EDP) is the route for degradation of glucose, while the PMSP serves 
an anabolic function (Lendzian and Bassham, 1952). In addition, 
differences in the activity of G6PD have been observed in the 
mammary glands of lactating and non-lactating mammals from the 
onset and cessation of lactation. Abraham and Chaikoff (1956) 
demonstrated that glucose was metabolized in the glycolytic 
pathway in the mammary glands up to the last day of pregnancy. 
Within a day after the delivery of the young ones, about half of the 
glucose was metabolized by way of the pentose shunt pathway, 
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which ceases to function a day after weaning. In contrast to the 
condition found in lactating mammals, there was a virtual absence 
of G6PD activity in the mammary glands of non-lactating animals, 
however, the activity of this enzyme rose during pregnancy and 
markedly increased several fold during lactation (dock and 
McLean, 1953; McLean, 1958; Baldwin and Yang, 1974). The 
differential activity of G6PD in tissues of male and female rats and 
humans appeared to suggest that the enzyme was modulated by 
various factors including dietary and hormonal mediators. 
Several studies including those of dock and McLean (1955), 
Tepperman and Tepperman (1959) and Fitch and Chaikoff, 1959) 
showed that the activity of G6PD underwent considerable 
fluctuations in response to starvation and refeeding; large increases 
were observed with low-fat diet containing complex 
polysaccharides. Although high-fat diet had been known to 
increase the activity of the enzyme, long chain fatty acids depressed 
it. In addition to the dietary mediators, gonadal hormones 
(estradiol and testosterone) and extragonadal hormones (thyroxine 
and insulin) were implicated in the modulation of G6PD activity. 
Estradiol 17-6 was shown to increase the activity of this enzyme in 
a dose-related manner in the liver (Huggins and Yao, 1959; Roux 
âl, 1972; Ibim slaL. 1989), and uterus of rats ( Hilf elaL 1972; 
Sartini aL 1973). However, in the bovine adrenal (McKerns, 
1962) and bovine corpora lutea (Nielson and Warren, 1965) a 
decrease in the activity of G6PD was reported after estradiol 
treatment. These differential effects in the activity of G6PD in 
response to specific hormonal treatment have also been 
demonstrated with testosterone. Dose-depended increases in the 
activity of G6PD were reported in male accessory organs of the rat 
(Ozols and Hilf, 1973; Brooks, 1975) while in the livers of male rats, 
the activity of G6PD decreased in response to testosterone 
treatment (Huggins and Yao, 1959; Roux siaL, 1972). In addition to 
the differential response following sex hormone treatment, 
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thyroxine and insulin were also implicated by acting either 
independently or in concert to modulate the activity of this enzyme 
(dock and McLean, 1953; Huggins and Yao, 1959; Hansen and 
Jungermann, 1987). 
Gel electrophoretic analysis of the purified G6PD on 
polyacrylamide revealed isozyme species in several studies. Hilf £i 
âi (1973), identified three molecular forms of G6PD in mammary 
glands of Balb/c mice that differed in relative amounts and 
proportion during pregnancy and lactation. These molecular forms 
were also observed in mammary preneoplastic and 
adenocarcinomas, with molecular weights ranging from 67000, 
137000 to 302000 (Hilf filai, 1975). In pregnant and lactating 
Fisher rats, the patterns of isozymes were altered and were 
different from those of the mice (Richards and Hilf, 1972; Hilf £iaL 
1975). The molecular weights of these isozymes correspond to 
dimer and tetramer (McKerns and Larson, 1974). However, in rat 
mammary carcinoma induced by 7, 12 dimethylbenz(a)anthracene 
(Richards and Hilf, 1971) and rat mammary adenocarcinoma 
R3230AC, specific alteration in the pattern of isozymes in response 
to castration or estrogen treatment were observed (Richards and 
Hilf, 1972). Estrogen treatment also produced only one isozyme 
species of G6PD in both mammary glands and the R3230AC strains. 
These studies provide little or no information on the development 
of this enzyme in various age groups and their relationship with 
various isozyme species. Huggins and Yao (1959), and Sholl and 
Leathern (1973) showed that the activity of G6PD in developing rats 
of 3-22 days was low but increased with a corresponding rise in the 
level of hormone. The PAGE analysis of this enzyme in rat tissues 
identified six bands designated A through F; one of the species 
designated as D was found to be absent in new born but present in 
adult male and female rats. However, electrophoretic analysis of 
G6PD from the breast of pregnant and lactating rats revealed three 
isozymes referred to as G6PD-1, G6PD-2 and G6PD-3 with the latter 
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isozyme remaining essentially unchanged, while G6PD-2 increased 
in both pregnancy and lactation, and G6PD-1 appeared in late 
pregnancy and lactation. 
These studies, suggested that the isozymes of G6PD and their 
molecular weights vary with specie differences and under varying 
metabolic conditions and treatment. Although pharmacological 
doses of estradiol and testosterone had been used to demonstrate 
stimulatory or inhibitory responses, it is not clear whether 
physiologically relevant doses will elicit similar responses in the rat. 
Additionally, the biochemical and molecular characteristics of G6PD 
from the chicken are not currently available, since this specie at the 
time of laying, is under the influence of high levels of circulating 
estradiol. In addition to the unknown molecular characteristics of 
this enzyme, there are inherent anatomical and physiological 
differences in the avian specie that render the chicken an 
interesting specimen of study. 
The proposed studies were designed to accomplish the 
following : 
1. Study the sex-related activity of rat hepatic G6PD by 
determining the effects of steroid hormones (estradiol-176 
and testosterone) in vivo . 
2. Isolate, purify and characterize G6PD from the livers of laying 
(36 week-old) and immature chickens (l and 12 week-old). 
3. Determine the developmental aspects of chicken liver G6PD by 
comparing the characteristics of the enzyme in mature (36 
week-old) and immature (1-12 week-old) chickens. 
CHAPTER II 
REVIEW OF LITERATURE 
A. G6PP: Discovery 
Glucose 6-phosphate dehydrogenase (G6PD) catalyses the 
conversion of glucose 6-phosphate to glucono-lactone-6-phosphate 
in the presence of nicotinamide adenine dinucleotide phosphate 
(NADP) or nicotinamide adenine dinucleotide (NAD). Warburg and 
Christian (1931) discovered the enzyme in horse erythrocyte and 
later in brewers' yeast in 1932. 
B. Pentose Pathway and Functions 
The monophosphate shunt pathway (PMSP) functions to 
generate NADPH and phosphate sugars (Axelrod, 1967) for the 
biosynthesis of nucleic acids (Keller, 1971; Eaton and Brewer, 1974) 
and of steroids biosynthesis. The precise role of the pathway in the 
oxidation of G6P is not clear, since functional variations have been 
observed in different tissues under varying metabolic conditions. 
Glock and McLean (1955) observed significant changes in the 
activity of rat liver G6PD in alloxan diabetes in response to 
starvation and treatment with thyroxine. Tepperman and 
Tepperman (1958) were the first to demonstrate in rat livers, the 
condition of adaptative hyperlipogenesis. The adaptation involved 
changes in the metabolism and large fluctuations in G6PD activity, 
in response to starvation and refeeding of various diets. These 
results have been reported previously (Yugari and Matsuda, 1976; 
Berdanier, 1981). The activity of the enzyme was inhibited by long 
chain fatty acids (Yugari and Matsuda, 1967). Fitch and Chaikoff 
(1960) further demonstrated the functional significance of G6PD in 
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generating reduced pyridine nucleotides (NADPH) for hepatic fatty 
acid biosynthesis. As a result of this study, a proposition was made 
that G6PD is the regulatory point of the oxidative aspects of PMSP in 
mammalian livers (Greenbaum and McLean, 1971; Novella et al, 
1969). Similar fluctuations in the activity of G6PD were observed in 
the mammary glands of many lactating animals during the onset 
and cessation of lactation (Baldwin and Yang, 1974). Abraham and 
Chaikoff (1956) made the observation that glucose was metabolized 
in the glycolytic pathway in the mammary glands up to the last day 
of pregnancy. Within a day after the delivery of the young ones, 
about half of the glucose was metabolized by way of the pentose 
shunt pathway, which ceased to function a day after weaning. In 
contrast to the condition found in lactating mammals, there was a 
virtual absence of G6PD activity in the mammary glands of non- 
lactating mammals. However, the activity of G6PD rose slightly 
during pregnancy and markedly increased up to sixty-fold during 
lactation (Glock and McLean, 1953; McLean, 1958; Baldwin and 
Milligan, 1966; Munford, 1968). The increased activity of G6PD 
correlated with increased demand for NADPH that is used for the 
biosynthesis of milk fat. 
C. Erythrocytes and G6PD 
In erythrocytes (red blood cells), reduced nucleotide (NADPH) 
generated by the pathway was used mostly as a coenzyme for the 
reduction of oxidized glutathione (GSSG) in a reaction catalyzed by 
glutathione reductase. The reduced form of glutathione (GSH) is 
essential for viable erythrocytes by maintaining the red cell 
structure and reduced hemoglobin (Keller, 1971; Eaton and Brewer, 
1974). Red cells from G6PD deficient individuals are unable to 
regenerate GSH from oxidized GSSG, therefore, the accumulation of 
hydrogen peroxide (H2O2) and other toxic radicals may damage the 
red cells as a result of the lack of the protective effect of GSH. G6PD 
deficiency had been associated with hemolytic anemia ; the 
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condition was worsened in some individuals that were sensitive to 
ingested antimalarial drug, primaquine (Yoshida and Beutler, 
1986;). Therefore, drugs and other compounds that decrease the 
bioavailability of NADPH or GSH by interfering with the normal 
metabolic function of the enzyme(s) may damage the red cells, thus 
producing hemolytic anemia. 
D. G6PD in Microbial Systems 
G6PD in some microbial organisms participates in multiple 
metabolic pathways. In some bacteria, two distinct G6PD were 
associated with the PMSP and the Entner-Doudoroff pathway (EDP) 
(Entner and Doudoroff, 1952). For example in Pseudomonads, the 
EDP was the route for degradation of glucose while the PMSP served 
as an anabolic function (Lendzian and Bassham, 1975). In some 
Pseudomonads, two separate G6PDs existed each associated with 
one of these metabolic pathways, while in others, a single G6PD 
served both anabolic and catabolic functions. One of the unique 
characteristics of such G6PD was the possession of dual nucleotide 
specificity (Vander Wyk and Lessie, 1974). For example, 
Leuconostoc mesenteroides , a microbial organism, possesses a 
single G6PD with specificity for both NAD+ and NADP+ (DeMoss, 
Gunsalus and Bard, 1953). G6PD from mesenteroides was very 
stable, unlike most mammalian enzymes. This stability has been 
shown to be due to the absence of cysteine in the amino acid 
sequence (Ishaque and Levy, 1974 ). 
E Sources and Isolation Procedure 
G6PD had been isolated and purified from various sources 
including microbial organisms (Olive and Levy, 1967, 1971). The 
isolation and purification has been carried out in plants (Muto and 
Uritani, 1970, Kickenscher and Scheibe, 1986). Similar studies in 
rats (Matsuda and Yugari, 1966; Ringer and Hilf, 1975; Donahue et 
al. 1981) mouse (Hizi and Yagil, 1976), bovine (Criss and McKerns, 
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1968; Singh and Squire, 1975) and humans (Yoshida, 1966; 1967; 
Dreyfus, 1974; Shreve and Levy, 1977) have been reported . 
Some laboratory procedures for the isolation of G6PD involve 
high speed centrifugation (10,000-110,000 x g ) to remove all 
extraneous and membrane fractions. The supernatant fraction 
(SNF) was purified using various steps including high salt or alcohol 
precipitation, anion and cation exchange and gel filtration 
chromatographic procedures. However, G6PDs from animal and 
fungal sources were characteristically very unstable and the loss of 
activity was probably due not only to instability but also 
endogenous proteolytic enzyme (plasmin), as for example in the 
case of human erythrocyte G6PD (Yoshida, 1966). The addition of 
amino-N-caproic acid or diisopropylfluorophosphate (DIFP) during 
purification was reported to be effective in protecting the enzyme 
against the action of plasmin (Yoshida, 1966). Meanwhile, Kahn si 
ai- (1974) reported the presence of a G6PD modifying factor that can 
be destroyed by endo and exopeptidases and serine proteases. Thus, 
the addition of proteolytic inhibitory substance may produce the 
undesirable effect of promoting the modification of G6PD while 
protecting this modifying factor. 
Stabilization of G6PD in mammalian tissues was enhanced by 
inclusion of NADP in the isolation buffers. It has been shown that 
the addition of NADP was effective in protecting the activity of 
G6PD in the isolation of Neurospora crassa G6PD that is known to be 
very unstable (Scott and Tatum, 1970). However, G6PD from 
Pénicillium duponti which was also very unstable appeared to 
respond to stabilization by G6P rather than NADP (Malcolm and 
Shepahard, 1972). In the isolation of G6PD from lactating 
mammary glands, 20% glycerol instead of NADP was used to 
stabilize the enzyme (Levy, 1963), however, Deflora el ai- (1973) 
found no stabilization in erythrocyte G6PD when glycerol was used. 
Goheer £iaL (1973) also found that G6PD Saccaromvces. cerevisiae 
was stabilized when the enzyme was immobilized on Sepharose 4B. 
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These studies suggested that stabilization of G6PD from mammalian 
and microbial sources may be affected by a number of different 
compounds. 
F. Properties 
1. Substrate specificity 
The natural substrate which gives the highest Vmax and the 
lowest Km for all G6PDs is glucose 6-phosphate (G6P), although 
other compounds with similar structures can also be oxidized. For 
example 2-deoxyglucose 6-phosphate can serve as a weak substrate 
for many G6PDs (Salas, Vinuela and Sols, 1965). 
2. Coenzyme specificity 
Until 1953, all studies with G6PD from mammalian and 
Saccharomvces. carlsbergensis showed that NADP but not NAD had 
specificity for G6PD. DeMoss  ai (1953) found that L_. 
mesenteroides G6PD had a dual specificity for NADP and NAD. 
Subsequent studies by Mortenson and Wilson (1954) and Cheldelin 
(1961) demonstrated that G6PDs from Azotobacter vinelandii and 
Azotobacter suboxvdans. respectively, possess dual nucleotide 
specificity for NADP and NAD. In lactating rat mammary glands and 
other mammalian tissues, Levy (1961) also showed that G6PD could 
react with a high concentration of NAD. 
3. Activation by mono/divalent cations. 
G6PD is known to be activated by most divalent cations, 
although the requirement of divalent cations for catalytic activity 
by this enzyme is not an absolute necessity. In pea chloroplast, 
Mg2+ is an absolute requirement for the catalytic activity of G6PD, 
however, in microorganisms such as Bacillus licheniformis with dual 
nucleotide specificity, the requirement for divalent cations showed 
opposing effects. Levy (1963), first reported that Mg2+ stimulated 
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NADP-linked reaction but inhibited those of NAD. In addition to 
Mg2+, other divalent or monovalent cations have been shown to 
activate G6PD from various sources. Niehaus and Dilts (1984), 
tested the effects of various monovalent cations on the activity of 
Aspergillus parasiticus from mycelium and found that all the 
monovalent elements including potassium (K), rubidium (Rb), 
cesium (Cs), sodium (Na), and ammonium (NH4), stimulated the 
enzyme at an optimum concentration of 25 mM. 
4. Effect of pH on G6PD activity 
G6PD from £* carlbergensis. L.. mesenteroides and human 
erythrocytes was used to study the effect of pH on kinetic constants. 
In 1976, Kuby and Roy, studied the effects of pH, temperature and 
constant ionic strength on the Vmax and Km of G6P and NADP in a 
solution of EDTA. They observed two groups on the enzyme with pk 
values of 5.7 and 9.2 at 25 C. Based on these studies, it was 
concluded that lysine (basic) and histidine ( acidic) were involved in 
the catalysis. 
G Effect of Estrogen on G6PD 
The sex hormones, estradiol (estrogen) and testosterone 
(androgen) have been found to elicit differential response to the 
activity of G6PD in mammalian tissues. Estradiol in low 
concentrations was found to inhibit G6PD from bovine adrenal 
(McKerns, 1962), bovine corpora lutea (Nielson and Warren,1965), 
and also decreased the level of hepatic G6PD in castrated female 
rats when challenged with 20-60 pg of estradiol. In contrast, the 
administration of estradiol elicited dose-related increase in the 
activity of G6PD from tumors (Huggins and Yao, 1959; Teppermann 
and Teppermann, 1964; Hori and Matsui, 1967; Criss, 1973; 
Berdanier, 1981; Ibim £ial, 1989); rat uterus (Moulton and Barker, 
1971; 1972; Hilf sial-, 1972); rat mammary tumors R3230AC and 
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rat mammary glands (Richards and Hilf, 1972; Criss, 1973; and 
hepatic tissues (Hansen and Jungermann, 1984). 
The administration of testosterone was also demonstrated to 
elicit differential response to specific or target tissue in rats. In 
androgen target tissues, Lerner £iaL(1968) demonstrated that the 
administration of testosterone propionate caused a dose related 
increase in the activity of male accessory organ G6PD. Ozols and 
Hilf (1973) also reported increases in the activity of G6PD in rat 
ventral prostate and seminal vesicles. Similar responses to 
testosterone challenge in the epididymus and epididymal 
spermatozoa of rats were also reported by Brooks (1975). These 
studies demonstrated that the tissues were targets for the androgen 
hormone and enzymes including G6PD present in these tissues may 
be androgen-dependent for their effects (Sholl and Leathern, 1973). 
However, in the liver, the administration of 500 |ig testosterone 
propionate decreased the activity of G6PD (Huggins and Yao, 1959). 
Roux (1972) observed a decreased response to G6PD activity 
in the liver of castrated male and female rats following the 
administration of testosterone. These effects were also confirmed in 
cultured hepatic liver cells of male and female rats. The addition of 
testosterone propionate in these tissues decreased the levels of 
estradiol-17B-induced increases in the activity of G6PD. In addition 
to the influence of sex hormones, extragonadal hormones have been 
shown to produce increases in the activity of G6PD. Huggins and 
Yao (1959) demonstrated that the administration of large doses of 
thyroxine increased the activity of hepatic G6PD in rats and similar 
response was mediated by insulin in hepatocytes of male and 
female rats (Hansen and Jungermann, 1987). In these studies, 
varying pharmacological doses were administered with different 
exposure rates. Thus, the exact role of these steroid hormones on 
the induction of G6PD is not clear, and the apparent discrepancies in 
these results could also be due to such variable factors. 
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H. G6PD and Isozymes 
Hilf £tal. (1973; 1975; 1976) demonstrated three forms of 
G6PD in mammary glands of Balb/c mice, that showed varied 
amounts and sizes during lactation and pregnancy. These multiple 
forms of G6PD also were observed in mammary preneoplastic 
tumors and adenocarcinomas. Using gel electrophoretic analysis, 
they showed that the molecular weights of these three isozymes 
were approximately 67,000; 137,000; and 302,000. The smallest 
form of these isozymes was shown to increase in adenocarcinomas, 
while the largest form was observed during lactation (Hilf, Ickowicz, 
Bartley and Abraham, 1975). 
In the Fischer rat mammary glands, three forms of G6PD were 
also observed on polyacrylamide gel electrophoresis. Richard and 
Hilf (1972) observed that there was a differential alteration in the 
amounts of these isozymes during lactation and pregnancy. At 
variance with these observations were the findings of McKenzie and 
Larson (1974) who showed a distribution of rat mammary G6PD in 
two forms with molecular weights similar to a dimer and tetramer. 
These observations were confirmed by Shreve and Levy (1974). 
Specific alterations in the pattern of G6PD isozyme were observed in 
ovariectomized estrogen-treated animals, when rat mammary 
carcinomas induced by 7,12-dimethylbenz(a) anthracene (Richards 
and Hilf, 1971) and rat mammary transplantable adenocarcinoma 
R3230AC (Richards and Hilf, 1972) were used. The administration 
of estrogen produced only one of the isozyme forms of G6PD in both 
mammary glands and the R3230AC adenocarcinoma (Richards and 
Hilf, 1972; Ringler and Hilf, 1975). Isozyme species of G6PD in 
human breast were demonstrated and differences were compared 
with normal and abnormal tissues. Isozyme forms of G6PD in 
response to specific hormonal treatment have been observed in the 
uteri of rats (Hilf, McDonald, Sartini, Rector and Richards, 1972; 
Sartini, Meadows, Rector and Hilf, 1973). In the ventral prostrate 
and seminal vesicles (Ozols and Hilf, 1973) of Fisher rats, mice (Hizi 
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and Yagil, 1974) and rat livers (Hori and Matsui, 1967; Schmukler, 
1970; Watanabe, Taketa and Kosaka, 1972), multiple forms of G6PD 
have been observed. These forms were shown to be different with 
respect to the molecular weights, relative amounts and sizes. 
Hori siaL (1967) identified six molecular forms of G6PD in rat 
tissues by means of electrophoresis. They found that one of the 
species designated as D, was the most active in adult male and 
female rats. This specie was also found to be absent in new born 
male and female rats. Richard and Hilf (1971) showed those 
isozymes of G6PD at various stages of differentiation were related to 
DNA, RNA and protein levels. They observed three isozymes 
referred to as G6PD-1, G6PD-2 and G6PD-3. They further observed 
that the latter isozyme remained essentially unchanged while the 
activity of G6PD-2 increased in pregnancy and lactation. G6PD-1 
appeared in late pregnancy and increased during lactation. They 
concluded that hormones play a discrete role in regulating the 
patterns of isozymes of G6PD during development and 
differentiation. It is not known if these isozyme patterns are 
similar or different from those in the chicken. 
I. Sex Differences and G6PD Activity 
Sex difference in the activity of hepatic G6PD in rats was first 
reported by Glock and McLean (1953; 1956). Other investigators 
(Slater e£ al_., 1964; Roux et ah, 1972; Winston and Reitz, 1979; 
Berdenier, 1981; Hansen and Jungermann, 1987; Ibim siai-, 1988; 
1989) have reported similar observations. This sex difference in 
the activity of G6PD may be due to the differential activity of many 
enzymes that develop at puberty (Knox si ai; 1956) in response to 
the secretion of testosterone or estradiol. Denef and Demoore 
(1972) showed that the pattern of enzyme development in male 
rats obtained in their study was not initiated primarily by 
testosterone at puberty but was due to a delayed differentiation 
predetermined to be an androgen. Huggins and Yao (1959) 
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reported that the activity of G6PD in female rats livers of 18-22 
days of pregnancy remained low until 53 days when the levels 
increased rather rapidly but declined at 4 months after birth. 
However, in the livers of male rats, G6PD levels did not rise during 
puberty. Sholl and Leathern (1973) observed an increase in G6PD 
levels in rats among 22 to 35 days of postnatal life. The activity of 
G6PD decreased in those animals following castration. 
Since most of these studies have been conducted in the rat or 
mouse specie using pharmacological doses, the differential 
responses in the activity of G6PD elicited by diet or hormone in 
various tissues may not represent physiological responses. In 
addition, the biochemical and molecular characteristics of G6PD 
from the livers of laying hens have not been studied, since in this 
specie, the level of estradiol that stimulates the activity of G6PD is 
high at the time of laying. Therefore, the purpose of this 
investigation was to examine the role of steroid hormones on the 
activity of G6PD as well as purify and characterize this enzyme. 
Data obtained from these studies will contribute to our 
understanding of the role of these steroids on the expression and 
molecular characteristics of G6PD in the rats as well as in the avian 
tissues. 
J. Justification of the study 
It has been shown that laying chickens possess a high level of 
circulating estrogen at the time of laying. Since relatively low levels 
of estradiol have been shown to promote increases in the activity of 
G6PD, the laying hens are naturally favored for such studies. The 
enzyme is naturally stimulated and maximally expressed in such 
animals. Furthermore, the chicken was chosen for this study 
because of the liberal availability of liver tissue. In addition, pre¬ 
stimulation of the enzyme with exogenous estradiol is 
circumvented, when laying hens are used in this investigation. 
Furthermore, G6PD is a sex linked enzyme. McIntyre and Angel 
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(1975) observed that the erythrocytes of G6PD-deficient individuals 
have a significantly higher lead content than in normal subjects. 
This suggests that G6PD is a biomarker of lead intoxication. Data 
derived from these studies may be useful for possible development 
of G6PD as a biomarker for lead toxicity. Although G6PD has been 
purified from various mammalians and bacterial sources, the 
biochemical and molecular properties of the enzyme from avian 
tissues are completely lacking. Because of the inherent anatomical 
and physiological differences in the avian specie and those of other 
mammalian tissues, there is a need to understand the biochemical 
and molecular properties of chicken liver G6PD. Knowledge 
obtained from this study will increase our understanding of the 
development of the enzyme and further contributes to the vast pool 
of information already available on this subject. 
K Experimental 
1. Specific Aim 1. 
Examine the effects of the administration of low doses of 
pelleted estradiol propionate (estradiol-17B ) on the activity of rat 
liver G6PD. Previous studies including those of Huggins and Yao, 
1959; Mckerns, 1962; Hori and Matsui, 1967; Moulton and Barker, 
1972 and Berdanier, 1981 had used pharmacological doses of 
estrogen in the mouse, rat and bovine tissue to elicit increased or 
decreased responses in the activity of G6PD. In this study, 
physiologically relevant doses of estradiol were administered to 
examine its effect on G6PD activity. Rats were castrated and 
pelleted estradiol (2.4, 4.8 and 7.2 pg/day/rat) implanted 
subcutaneously as previously described by Ozols and Hilf (1973), 
for two weeks. Animals were sacrificed and livers were used for 
the determination of G6PD activity. 
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2. Specific Aim 2 
Examine the effects of low doses of testosterone propionate on 
the activity of rat liver G6PD. The effects of testosterone hormone 
on the activity of G6PD appear to elicit varied responses. G6PD 
activity decreased in the liver in response to testosterone treatment 
(Roux £ial. 1972). However, the activity of G6PD increased in the 
prostate glands and in muscle tissues of rats following T treatment 
(Longscope et al. 1978). This experiment was designed to examine 
whether low doses of testosterone are stimulatory or inhibitory in 
rats. The experimental set up and methods used were essentially 
the same as in specific aim 1. 
3. Specific Aim 3. 
Purify and characterize G6PD from Chicken livers. G6PD has 
been studied in various tissues of bacteria, plants, rats, bovine and 
human. The biochemical characteristics of this enzyme in the avian 
tissue (Chicken liver) are largely unknown. The purified enzyme 
was characterized to examine the compatibility of its biochemical 
and molecular properties relative to the reported values of other 
mammals. The liver cytosol was purified using various reagents 
including ethanol, ammonium sulfate, DEAE, acid treatment and CM 
cellulose chromatographic separation techniques. The purified 
enzyme was used to study the kinetic behavior of the enzyme. 
4. Specific Aim 4. 
Determine the specificity of substrate for the enzyme. The 
natural substrate for the enzyme is the compound that gives the 
highest Vmax when oxidized in the presence of G6PD. Specificity of 
the substrate for chicken liver G6PD was determined by assaying 
the activity of the enzyme in the presence of varying concentrations 
of sugars including G6P, GIP and glucose, and the concentration of 
NADP was constant. The Km (affinity) of these sugars for the 
enzyme was determined. 
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5. Specific Aim 5 
Determine the specificity of the cofactor for the enzyme. 
G6PD is capable of reducing other nucleotides such as NAD. The 
specificity of the cofactor, for the enzyme was examined, by 
studying varying concentration of NADP, NAD and FAD in reactions 
catalyzed by the enzyme, while the substrate remained constant. 
The Km of these nucleotides was determined. 
6. Specific Aim 6 
Determine the effects of cations on the activity of G6PD. Most 
mammalian and microbial G6PD's are known to be stimulated by 
cations. The effects of the cations on the activity of chicken liver 
G6PD were examined by determining the activity in the presence of 
varying concentrations of monovalent cations (KC1, NaCl and NH4CI) 
and divalent cations (cadmium, cobalt, manganese, manganese and 
zinc). The chloride form of these cations was used in this study. 
7. Specific Aim 7 
Determine the stability of the purified G6PD. The stability of 
the purified enzyme was examined in the presence and absence of 
NADP, at room temperature, and heating at various temperatures. 
The effect of substrate and other sugars on the stabilization of G6PD 
was also examined. 
8 Specific Aim 8 
Determine the effect of pH. The effect of pH on the activity of 
G6PD was examined by assaying the activity in buffers at pHs 
ranging from pH 5.0 through 10.5. This study provided information 
on the pH optimum of the enzyme. 
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9. Specific Aim: 9 
Examine the developmental aspects of G6PD in immature (1- 
12 week-old) and 36 weeks-old female chicken as well as in male 
chicken (36 weeks-old). The age-related differences in the activity 
of G6PD had been used in part to assess the development of many 
enzymes including G6PD (Huggins and Yao, 1959, Mersmann and 
Honk, 1971). The sex difference in the activity G6PD in the rat has 
been reported previously, however, the sex difference in the 
activity of this enzyme in the chicken is not known. The activity of 
G6PD was assayed from the 36 week-old male and female chicken 
as well as those of the 12 and 1 week-old. The isozyme patterns of 
G6PD from the livers of these animals were also studied and 
compared. 
CHAPTER III 
MATERIALS AND METHODS 
A. Animals 
1. Rats 
Sprague-Dawley male and female rats (100-110g) were 
purchased from Charles Rivers Laboratories, Wilmington, Mass, and 
maintained in a temperature-controlled animal-care facility.at 
Atlanta University Center, Atlanta, Georgia. Hormone-free 
laboratory rodent feed and water were provided ad libitum. Food 
and water consumed were recorded bi-weekly and replaced every 
other day. 
2. Chicken 
Rhode Island Red chickens were used in this study. The 
chickens were purchased from a local farmer. Their livers upon 
sacrifice, were placed upon dry ice or quickly frozen on liquid 
nitrogen and used immediately or stored at -70 C until used later. 
B. Çfremiçals 
Pelletized estradiol and testosterone propionate were 
purchased from Innovative Research of America, Toledo, Ohio; 
nicotinamide adenine dinucleotide phosphate disodium salt (NADP); 
glucose 6-phosphate tetrasodium salt, (G6P); fructose 6-phosphate, 
glucose, 6-mercaptoethanol, L mesenteroides G6PD, glucose oxidase, 
hexokinase, BSA, myoglobin, DEAE-Cellulose and CM-Cellulose were 
purchased from Sigma Chemical Co. St. Louis, Mo. Electrophoretic 
reagents were analytical grade and were purchased from Fisher 




LKB spectrophotometer; Gelman Densitometer (Model XL) 
Spectrophotometer model Acta 111 (Beckman); LKB Fraction 
Collector , Beckman Ultra centrifuge model L8-70, were used during 
the purification of G6PD and protein quantification. 
D. Castration and Treatment 
Castration of male rats was performed under ether anesthesia 
as previously described by Ozols and Hilf (1973). The scrotal sacs 
were cut and the testes were individually isolated and excised after 
the spermatic cords were ligated. Castration in the female rats was 
also performed under ether following the method previously 
described by Hilf £iai-, (1972), by making lateral incisions at the 
lumber region. The ovaries were removed and the incisions closed 
by wound clips. The rats were allowed to recover for seven days 
before use for experiments. 
Rats were divided into control and treatment groups. The 
control group consisted of intact (IC) or castrated (CC) male and 
female rats. The treatment group (Treated) consisted of intact and 
castrated male and female rats. Each group consisted of at least 8 
rats per treatment for estradiol and 3 rats per treatment for 
testosterone (2.4, 4.8 and 7.2 pg/day) by subcutaneous 
implantation. The control groups received corn oil via the same 
route. The initial body weights were recorded eight days after 
castration and final weights recorded before sacrifice. Blood 
samples were obtained for determination of plasma estrogen or 
testosterone. 
E Hormone treatment 
Estradiol (E2) : In order to ensure a slow sustained exposure 
to hormone, pelleted 17-B estradiol propionate was implanted 
subcutaneously in three dose levels of 50, 100 and 150 pg/rat. The 
pellets were designed for a three-week controlled dose-dependent 
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release, with effective exposure of 2.4, 4.8 and 7.2 pg/day. Blood 
samples were analyzed for both endogenous as well as the level of 
circulating E2. 
Testosterone (T) : In another experiment, pelletized 
testosterone propionate with effective dose of 2.4, 4.8 and 7.2 
pg/day were also implanted subcutaneously as before. Blood 
samples were obtained on the day of sacrifice. Plasma testosterone 
was determined according to the method previously described by 
Perchio £i al-,(1977). 
F. Tissue preparation and enzyme assay 
1. Tissue Preparation 
The rats were sacrificed by rapid decapitation at the end of two 
weeks and their livers were removed for the assay of G6PD activity. 
Liver tissue tissue (1.0 g to 3 ml of buffer) was homogenized in 50 
mM Tris-HCl buffer, containing O.lmM EDTA, ImM 6- 
mercaptoethanol, pH 8.5. The homogenate was centrifuged at 
110,000 x g for 1 hr in a Beckman ultracentrifuge, L8 and the 
supernatant fraction (SNF) was used for the assay of G6PD. Unless 
otherwise stated, the conditions for preparation of tissue for 
enzyme assay and purification were essentially the same as 
previously described by Ibim £tai- (1989). 
2. Enzyme Assay 
G6PD was assayed spectrophotometrically under standard 
conditions as described previously (Ibim giaL, 1989), and 
Bergmeryer (1965), respectively, at 25 C. Unless otherwise stated, 
the assay mixture consisted of 50 mM Tris, pH 8.5, 0.1 mM EDTA, 
O.lmM 6-mercaptoethanol, 0.2 mM NADP, 0.5 mM G6P and 0.5 mM 
MgCl2- The reaction was initiated by adding 10-20 pi of enzyme 
solution into a cuvette containing 1.0 ml of the assay mixture and 
the increase in absorbance of NADPH at 340 nm was expressed as 
Units or mUnits. A unit of G6PD activity is the amount that will 
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cause the transformation of one micromole of substrate in one 
minute at 25 C under optimal assay conditions 
G Protein: 
Protein was quantified using the Biorad protein assay 
developed by Bradford (1976). A standard curve was prepared 
using BSA as the standard protein. Aliquots of the unknown 
samples were added to tubes containing diluent buffers, and 
thereafter, 5 ml of Biorad dye (diluted 1:4) was added to each tube 
including blanks and the absorbance was determined at 595 nm. 
The amount of protein was then extrapolated from the standard 
curve. Protein from the elution fractions of gel filtration (G-200), 
DEAE and CM celluloses was determined spectrophotometrically at 
absorbance of 280 nanometers. 
H. Statistical Analysis 
The differences in the activity of G6PD between control and 
treated groups were analyzed by using the Student's'T'test at a 
confidence level of 0.05 %. 
I. Purification of G6PD 
1. Crude Extraction : 
Chicken livers (100-130 g) were homogenized with a Virtis 
homogenizer in an ice bath in three volumes of 100 mM Tris buffer, 
pH 8.5 containing 0.1 mM EDTA, O.lmM, 6-mercaptoethanol, 5.0 % 
glycerol and O.lmM NADP, 0.25 M sucrose. Subsequent steps in 
purification were performed according to Matsuda and Yugari, 
(1966) but modified when necessary, for this experiment. The 
homogenate was centrifuged at 40,000 rpm for 1 hr at 4 C using 
Beckman Ultracentrifuge, model L8-70M. The cytosol resulting 
from this centrifugation was used for determining the activity of 
G6PD and the next step of purification. The conditions for the 
enzyme assay have been described under enzyme assays. 
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2. Ethanol treatment : 
Ethanol (95%) previously chilled to 4 C was added to the 
110,000 2L_£ SNF with mechanical stirring to a final concentration of 
25% (v/v). After the mixture had been stirred for another 30 min, 
the clear SNF was obtained by centrifugation at 10,000 x g for 20 
min.at 4 C. 
3. Zjn.ç Açetate precipitation; 
The resulting SNF was precipitated with 0.1 M freshly 
prepared zinc acetate solution, with constant stirring for about 30 
min. The precipitate was collected by centrifugation at 10,000 x g 
for 20 min., reconstituted in about one-fifth of the homogenate 
buffer and dialyzed in two changes of 0.1 M potassium phosphate, 
pH 7.0 containing 5% glycerol, 0.1 mM 6-mercaptoethanol and 0.1 
mM EDTA. The dialysate was chromatographed on DEAE-Cellulose. 
4 Ammonium Sulfate (0-25%) 
The pellet resulting from zinc acetate precipitation was 
reconstituted to the original volume to which solid ammonium 
sulfate was added to 25 % saturation with constant stirring until 
desolved. The slurry solution was centrifuged at 10,000 x g for 20 
minutes. The supernatant solution was concentrated with 
ammonium sulfate to 80% saturation and the pellet was recovered 
by centrifugation at 10,000 x g for 20 minutes. The pellet was 
dialyzed against two changes of 0.01M phosphate buffer, pH 7.0. 
This step is not a part of the procedure of Matsuda and Yugari 
(1967). 
5 DEAE ChrQmGlQ.grgphy; 
The column (53 x 2 cm) was pre-equilibrated with potassium 
phosphate buffer, pH 7.0. The enzyme extract was 
chromatographed and washed with four-bed volumes of the same 
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buffer until the protein concentration was nearly zero or negligible 
at 280 nm. The column was then eluted with 0.2 M K2HP04at pH 
7.0. The active fractions were pooled, precipitated to 80% 
saturation with ammonium sulfate and the pellet recovered by 
centrifugation at 10,000 2L_g. for 20 min. at 4 C . 
6. Acid treatment: 
The pellet was reconstituted in 0.005 M ammonium acetate buffer, 
pH 6.5 containing 1 x 10'3 M NADP, 5% glycerol, 0.001 M 6- 
mercaptoethanol, and dialyzed in two changes of two liters of the same 
buffer. To the dialyzed extract was added 1 x 10*3 M NADP, with 
constant stirring followed by 0.005 M ammonium acetate and the final pH 
adjusted to 5.5. The clear supernatant following centrifugation at 10,000 
x g for 20 min and further chromatographed on CM Celllulose. 
7. CM chromatography: 
The SNF resulting from the acid precipitation was 
chromatographed on a cation exchanger previously equilibrated 
with 0.005 M ammonium acetate, containing 1 x 10"3 M NADP, 
0.001 M 6-mercaptoethanol, 1 x 10'3 M EDTA and 5% glycerol, pH 
5.5. The column was washed with four volumes of the same buffer 
and eluted with 0.2 M ammonium acetate buffer, pH 6.0 containing 
0.01 M NADP. The active fractions containing G6PD were pooled, and 
concentrated with 80% ammonium sulfate. The precipitate was 
recovered by centrifugation and dialyzed for DEAE cellulose 
chromatography. 
8 DEAE Chromatography: 
The column was pre-equilibrated with phosphate buffer, pH 
7.0. The dialyzed enzyme extract was chromatographed and washed 
with four-bed volumes of the same buffer until the protein 
concentration was negligible at 280 nm. The column was then 
eluted with 0.2 M PO4 containing 0.1 mM NADP at pH 7.0. The 
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active fractions was pooled, precipitated to 80% saturation with 
ammonium sulfate and the pellet recovered by centrifugation at 
10,000 x g for 20 min.at 4 C. The activity of G6PD following this 
treatment was over 4000 fold relative to the crude homogenate 
cytosol and 62 Units/mg protein. 
J. Isozvmes and Molecular weight 
1. Determination of Isozymes 
The isozymes of G6PD were determined on 5.5% 
polyacylamide gel (native) according to Hedrick and Smith (1968). 
in 0.025 M Tris-glycine, pH 8.3. Electrophoresis lasted for at least 18 
hr at 20 mA/gel. Liver cytosol containing 0.02 units/mg protein 
was diluted 1:15 with 40% sucrose containing 0.1 M NADP, and 
applied to the gel. Protein was revealed by staining with 
amidoschwartz or coomassie blue after fixing with trichloroacetic 
acid. Glucose 6-phosphate dehydrogenase activity was specifically 
stained with a solution of 0.2 M Tris-HCl, pH 8.0, containing 0.01 M 
MgCl2 , 2 x 10-  * 4 M NADP, 6 x 10'4 M G6P, 2 mg/20 ml phenazine 
methosulfate and 4 mg/20 ml tétrazolium salt MTT. Stain- 
identified G6PD isozyme bands on preparative electrophoresis were 
cut individually and the proteins were isolated, and applied on 10 % 
SDS-PAGE for molecular weight, determination. 
2. Determination of Molecular Weight 
The molecular weight of G6PD was estimated using Sephadex 
G200. The column (64 x 1 cm) was equilibrated in 0.005 M sodium 
phosphate, pH 8.0 containing 0.1 mM EDTA, 0.001 M NADP and 
O.lmM 6-mercaptoethanol. Blue Dextran (0.1%), glucose oxidase 
(150.000) , Hexokinase (100,000), BSA (68,000) and myoglobin 
(17.000) were used as markers. Protein was eluted and a standard 
curve was derived by plotting the log molecular weight of the 
markers versus the heights of their peaks. The molecular weight of 
G6PD was extrapolated from the standard curve. 
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3. Preparative pel electrophoresis 
To further purify the enzyme, preparative electrophoresis was 
performed according to the procedure of Kahn and Dreyfus ( 1974.), 
using 6-7% gel. Electrophoresis was performed as previously 
described, using L- mesenteroides G6PD as standard in a second slab 
gel. Following electrophoresis, G6PD band was identified, stained 
and aligned end to end with the second gel. The position of chicken 
liver G6PD was identified and removed by cutting. The gel strip 
containing the enzyme was crushed in pre-cooled mortar in Tris 
buffer, pH 8.5. The filtered SNF was chromatographed on DEAE 
cellulose and eluted with NADP at 4 C The enzyme recovered by 
ammonium sulfate precipitation was used for further determination 
of the enzyme purification and G6PD subunits on SDS-PAGE. 
4. Sodium dodecvlsulfate polyacrylamide gel electrophoresis: 
SDS-PAGE was performed as previously described by Weber 
Êial (1972), with modification using 10% polyacrylamide. Proteins 
were prepared for electrophoresis by incubating for 5 min. in 1% 
SDS-1% mercaptoethanol at 100 C In determining the molecular 
weight by SDS gel electrophoresis, the following molecular markers 
phosphorylase b (94,000), bovine serum albumin (68,000), 
ovalbumin (45,000) carbonic anhydrase (31,000), and Soybean 
Trypsin inhibitor (22,000) were used as standards . 
K Enzvme Kinetics 
1. Determination of substrate specificity 
The natural substrate of the enzyme is usually the compound 
which gives the highest Vmax. The substrate specificity of the 
enzyme was determined by assaying the activity of G6PD in the 
assay mixture containing varying concentrations of G6P, G1P and 
glucose as substrate while NADP concentration were kept constant. 
The affinity (Km ) of these sugars for the enzyme was determined. 
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2. Cofactor specificity 
The specificity of the cofactor (nucleotide) for the enzyme was 
studied in the same manner as the substrate except that varying 
concentrations of NADP, NAD and FAD were used in the assay 
mixture. The assay mixture was essentially the sapie as described 
except that the concentration of the cofactors were varied. The 
concentration of G6P was kept constant. The Km of these 
nucleotides was determined. 
3. Effect of Monovalent cations 
The effects of monovalent cations on the activity of G6PD were 
studied by assaying the activity of the enzyme in the presence of 
varying concentrations of potassium, ammonium and sodium 
chloride ions. The assay condition is essentially the same except 
that Tris base (50 mM) was used as the buffer and MgCl2 was 
excluded in the assay system. 
4. Effect of Divalent Cations 
The effects of divalent cations on the activity of G6PD were 
also determined by measuring the activity of the enzyme in the 
presence of varying concentrations of cadmium, magnesium, 
manganese, nickel and zinc chloride ions. The assay buffer (Tris 
base) was essentially free of these cations and the enzyme was 
dialyzed prior to use. 
5. Effect of-pEL 
The effect of changing the pH on the activity of the purified 
enzyme was studied by altering the pH from 5.0 through 10.5. The 
enzyme containing about 100 ug protein was added to cuvette 
containing assay mixture of specified pH. The following buffers 
were used: Tris acetate (5.0-5.5); Histidine HC1 and Pyrophosphoric 
acid (6.0 - 6.5), Imidazole (7.0-7.5), Tris-glycine (8-8.5), Histidine 
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base and Ethanolamine (9.0-9.5), Trimethylamine and Methylamine 
(10.0-10.5), Diethylamine and Ascorbate (11.0 - 11.5). 
6. Stability of G6PD 
G6PD is not stable, therefore, treatment conditions at room 
temperature and heating at various temperatures were 
investigated. NADP is thought to provide some measure of 
protection against the loss of G6PD activity (Levy, 1963). 
(a ) Ambient temperature 
The purified enzyme was used for this study. NADP (0.1 mM) 
was added to aliquots of the enzyme containing about 100 ug 
protein and a parallel study in which NADP was absent. The 
activity of G6PD was monitored spectrophotometrically at 30 min. 
intervals and the data were expressed as percent activity over time 
(hr). 
(b) Thermostability 
The purified enzyme was heated at 37, 42, 47, 52, 57 and 62 
C. In another study, the enzyme was further heated to 50 C in the 
presence of 0.3 mM NADP for 20 mins and control study in which 
NADP was absent. G6PD is thermolabile and the activity will be lost 
within 5 mins at this temperature, without the protection of NADP. 
The activity of G6PD was determined and expressed as percent 
activity versus temperature (C). 
L. The Effect of Age and Sex on the Activity of G6PD 
Age :The developmental patterns in the activity of G6PD 
(Units/mg protein) were determined by analyzing SDS-PAGE 
profiles and comparing the activity of the enzyme in the immature 
female chicken (1 and 12 week-old), and the adult laying hen (36 
week-old). 
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Sex : The sex-related differences in the activity of G6PD were 
also determined by comparing the activity of the enzyme in adult 
(36 week-old) male and female chickens. Enzyme activities were 
assayed in triplicate. The differences and levels of significance 
(95%) were determined using the Student's T test analysis. 
CHAPTER IV 
RESULTS 
A: Effects of Castration and Estradiol Administration on Food 
Intake, Body and Uvgr Weights 
Table 1 represents the body and liver weights as well as the 
food intake pattern of rats used in this study. The rats were 
selected from a homogeneous pool, therefore the initial body 
weights of male and female rats were identical and did not reflect 
any sex differences. Castrated male rats decreased weight gain as 
compared to the intact control (19% IC, 12% CC). However, in 
contrast to castrated male rats, the weight-gain in intact male rats 
was higher after estradiol (E2) supplementation. These differences 
in body weight correlated with food consumption. Intact rats 
consumed about 4 gm/day more than castrated counterparts (32 g 
IC., 28 g CC.). In intact female rats, the changes in weight gain were 
similar (Int.,9.5%, Cast., 9%), but increased slightly after E2 
treatment in intact females (10 g: IC. treated, 7.5 g: CC.). Estradiol 
treatment however, resulted in an increase in food consumption in 
intact female rats (29 g) as compared to female castrates (23 g). 
Liver weights of intact control male rats were approximately 2 g 
more than in castrated male counterparts (16g versus 14 g). In E2- 
treated male rats, however, liver weights were essentially similar 
and estradiol treatment did not produce a significant effect, 
although in castrated female rats there was a slight reduction in 
liver weight. 
B. Effects of Estradiol Administration on the Activity of G6PD 
Figure 1 shows the enzyme activity response to estradiol 
treatment in the intact male and female rats and controls. The 
30 
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TABLE 1. Effects of Castration and Estradiol Administration on 
Food Intake, Body and Liver Weights of Rats. 
Treatment 
Body Weight (g) 






Int.Cont. 282 ± 2.6 350 ± 5.3 19 17 ±0.2 32 ± 1.2 
E2 (2.4 ) 274 ± 2.5 362 ± 4.6 24 16 ±0.3 34 ± 1.2 
E2 (4.8) 281 ±2.9 375 ± 3.8 25 16 ±0.3 30 ± 1.0 
E2 (7.2 ) 288 ± 3.4 344 ± 4.3 16 15 ±0.3 32 ± 0.9 
Cast.Cont. 292 ± 3.2 331 ±4.0 12 14 ±0.1 27 ± 0.6 
E2 (2.4 ) 300 ±3.1 335 ± 4.2 12 14 ±0.1 29 ± 0.8 
E2 (4.8) 308 ± 3.5 338 ± 4.5 8 15 ±0.3 28 ± 0.8 
E2 (7.2) 294 ± 3.2 323 ± 3.0 9 14 ±0.2 29 ± 0.8 
FEMALE 
Int.Cont. 285 ± 2.9 315 ±3.0 10 16 ±0.3 28 ± 0.8 
E2 (2.4) 282 ± 3.4 313 ±2.9 10 14 ±0.2 29 ± 0.8 
E2 (4.8) 280 ± 4.3 315 ±3.9 11 15 ±0.3 31 ±0.8 
E2 (7.2) 278 ± 3.2 309 ± 3.5 10 14 ±0.2 29 ± 0.6 
Cast.Cont 274 ± 2.5 300 ± 3.2 9 11 ±0.1 22 ± 0.4 
E2 (2.4 ) 276 ± 2.5 296 ± 4.2 7 11 ±0.1 20 ± 0.2 
E2 (4.8) 280 ± 2.8 300 ± 3.3 7 10 ±0.1 25 ± 0.6 
E2 (7.2 ) 273 ± 2.4 298 ± 3.8 8 10 ±0.1 23 ± 0.4 
Mean Body wt. and Food (g) ± SD, N = 8. Experimental conditions, 
unless otherwise stated, are essentially the same as described under 
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activity of G6PD (Units/mg protein) in control rats showed a sex 
difference when compared to their male counterparts (Female:0.094 
± 0.005, Male:0.029 ± 0.004). Differences as a result of sex were 
preserved despite hormone treatment. The activity of G6PD in intact 
male rats following estradiol supplementation increased to 0.121 ± 
0.01, 0.130 ± 0.01 and 0.161 ± 0.01 at dose levels of 2.4, 4.8 and 7.2 
jxg/day. In female rats, the stimulation of G6PD activity markedly 
increased from 0.094 ± 0.005 (control) to 0.203 ± 0.008, 0.236 ± 
0.007 and 0.251 ± 0.01 at similar rates of exposure. 
The activities of G6PD in E2-supplemented intact and castrated 
male rats are also compared in Figure 2. The activities of the 
enzyme decreased slightly (28%) in castrated-control males rats 
compared to intact males rats (0.021 ± 0.004 versus 0.029 ± 0.004). 
E 2- administration to intact males caused a significant (Pc.01) 
increase in the activities of G6PD from 0.028 ± 0.004 units/mg 
protein, (control) to 0.121 ± 0.01, 0.130 ± 0.01 and 0.161 ± 0.01 
(treated) corresponding to the dose rates of 2.4, 4.8 and 7.2 |ig/day 
respectively. Estradiol treatment further caused increases in the 
activity of G6PD in male castrates from 0.021 ± 0.003 (control) to 
0.158 ± 0.007, 0.198 ± 0.011 and 0.210 ± 0.009 units/mg protein 
(treated) in a dose-dependent manner. 
The activities of G6PD following E2 administration to intact 
and castrated female rats are compared in Figure 3. Castration 
decreased the activity of this enzyme by 25% in intact females 
(0.093 ± 0.005 IC; 0.071± 0.01 T), however, E2-supplementation 
significantly (Pc.01) increased the enzyme activity in castrated 
females to 0.146 ± 0.004, 0.175 ± 0.008 and 0.186. ± 0.006 
units/mg protein corresponding to exposure rates of 2.4, 4.8 and 
7.2 flg/day, respectively. In contrast to male castrates which 
showed greater sensitivity to stimulation, the activities of G6PD in 
response to estradiol stimulation was higher in intact than those of 
castrated female rats (0.093 ± 0.005 IC to 0.204 ± 0.009, 0.235.± 
Fig. 2 Effect of Estradiol Administration on the Activities of G6PD 
in Castrated and Intact Male Rats. Treated rats received 
2.4, 4.8 and 7.2 pg/day/rat pelleted estradiol propionate by 
subcutaneous implantation and control rats received corn 
oil. Histograms represent mean specific activity of G6PD 
(Units/mg protein ) ± SD of 8 rats in each treatment or 
control. Tissue preparation and enzyme assay conditions 
have been described under materials and methods. All 
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Fig. 3 Effect of Estradiol Administration on the Activities of G6PD 
in Intact and Castrated Female Rats. Treated rats received 
2.4, 4.8 and 7.2 pg/day/rat of pelleted estradiol propionate 
by subcutaneous implantation and control rats received 
corn oil. Histograms represent mean specific activity of 
G6PD (Units/mg protein) ± SD of 8 rats in each treatment or 
control. Tissue preparation and enzyme assay conditions 
have been described under materials and methods. All 
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0.007 and 0.251 ± 0.012 units/mg protein (treated) at similar 
exposure rates. 
Figure 4 shows the activities of G6PD in intact control (IC) and 
castrated (CC) male and female rats as well as E2 treated rats. In 
intact rats, the activities of G6PD enzyme was 3-fold higher in 
females as compared to their male counterparts (0.094 ± 9.47 
versus 0.029 ± 0.004). Castration caused a 25% decrease in the 
activities of this enzyme in female rats from 0.094 ± 0.005 (intact) 
to 0.071 ± 0.009 (castrate), but did not eliminate the the sex 
difference. The corresponding values for the males were 0.028. ± 
0.004 (intact) and 0.021 ± 0.004 (castrated). In E2-treated female 
rats, the activity of G6PD increased from 0.071 ± 0.009 (CC) to 0.146 
± 0.004, 0.175 ± 0.008 and 0.186 ± 0.006 units/mg protein (treated) 
corresponding to dose levels of 2.4, 4.8 7.2 (ig/day respectively. 
These enhancements were significantly (Pc.01) different when 
compared to the intact or castrated controls. In male castrates the 
activities of G6PD also increased following estradiol supplementation 
but at mid and high dose levels, differences due to sex were 
abolished. 
C The Effects of Castration, and Testosterone Administration on 
Weight-gain. Liver Weight and Food Intake. 
Table 2 shows the effects of castration, and testosterone (T) 
administration on weight-gain, liver weight and food consumption of 
male and female rats. Castration decreased weight-gain in both 
male and female rats as compared to intact control rats (12% IC., 8% 
CC), and in female rats (10 % IC, 4% CC.). Testosterone administration 
in intact male rats promoted an increase in food intake as compared 
to non-treated intact male rats (32 g ± 2.4 CC., 48 g ± 3.6 treated). 
However, weight-gain and liver weights of T-treated intact rats 
decreased or remained essentially unchanged with increasing T dose 
levels. Similar effects were observed in female intact rats, following 
T administration. The food consumption of female rats in contrast to 
Fig. 4 Summary of Effect of Estradiol Treatment on the Activities 
of G6PD in Castrated Male and Female Rats as well as 
Intact and Castrated Controls. Histograms represent mean 
specific activity of G6PD (Units/mg protein ) ± SD of 8 rats 
in each treatment or control. Tissue preparation and 
enzyme assay conditions have been described under 
materials and methods. All treatments were significantly 
























TABLE 2. Effects of Castration and Testosterone Administration 
on Food Intake, Body and Liver Weights of Rats 
Treatment 
Body Weights (g) 






Int. Cont. 367 ± 3.5 415 ±5.8 12 16 ±0.3 32 ± 2.4 
T2 (2.4) 438 ±6.1 476 ± 6.4 8 17 ±0.4 46 ± 3.2 
T2 (4.8) 449 ± 6.4 470 ± 6.8 4 16 ±0.3 47 ± 3.3 
T2 (7.2) 454 ± 6.4 467 ± 6.8 3 15 ± 0.2 48 ± 3.6 
Cast. Cont. 308 ± 3.5 335 ± 4.3 8 13 ±0.3 27 ± 1.8 
T2 (2.4) 312 ±2.9 326 ± 4.0 4 11 ±0.2 25 ± 1.5 
T2 (4.8) 305 ± 3.4 325 ± 4.0 6 12 ±0.2 27 ± 1.8 
T2 (7.2) 298 ± 3.3 325 ± 4.0 8 14 ±0.3 30 ± 2.0 
FEMALE 
Int. Cont. 238 ± 2.9 264 ± 2.0 10 11 ±0.2 26 ± 1.9 
T2 (2.4) 230 ± 2.4 243 ±3.1 6 10 ±0.1 21 ± 1.2 
T2 (4.8) 230 ± 2.4 250 ± 3.3 8 10 ±0.1 20 ± 1.0 
T2 (7.2) 236 ± 2.5 258 ± 3.0 8 10 ±0.1 22 ± 1.3 
Cast. Cont. 269 ± 2.8 296 ± 4.3 9 10 ±0.1 23 ± 1.2 
T2 (2.4) 238 ± 2.9 314 ±3.4 24 13 ±0.2 25 ± 1.6 
T2 (4.8) 250 ± 3.3 318 ±3.8 22 12 ±0.2 26 ± 1.0 
T2 (7.2) 247 ± 3.5 310 ±4.0 20 12 ±0.2 28 ± 2.4 
Mean Body Wt. and Food Intake (g) ± SD, N = 3. Experimental 
conditions unless otherwise stated, are essentially the same as described 
under materials and methods. 
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their male counterparts decreased when compared to the control ( 
26 g ± 1.2 CC., 22 g ± 1.3 Treated). Furthermore, the body weight 
(10 % CC., 8% T) and liver weight (11 g CC., 10 g Treated) also 
decreased in female intact rats following T treatment. In castrated 
male rats,T administration decreased weight-gain (8% CC, 6% 
Treated) and liver weight (13 g CC. , 12 g Treated) without 
significant change in food consumption (27g CC versus 27.3 g 
Treated). However, in female castrates, T administration caused an 
increase in weight-gain (9% CC., 23 % Treated), increased liver 
weights (10 g CC., 12 g Treated) and food consumption (23 g CC 
versus 26 g Treated). 
D. The Effects of Testosterone Administration on the Activity of 
Hepatic G6PD 
The effect of testosterone treatment on the activity of G6PD 
(Units/mg protein) in intact (IC) male and female rats are compared 
in Figure 5. The administration of small doses of testosterone 
(Treated) decreased the activities of G6PD in male intact rats (0.026 
± 0.004 IC vs 0.018 ± 0.003, 0.02 ± 0.003 and 0.024 ± 
0.004.Treated) relative to 2.4, 4.8 and 7.2 (Xg/day exposure rates. In 
intact female rats, the activity of G6PD also decreased from 0.071 ± 
0.004 (IC) to 0.054 ± 0.004, 0.057 ± 0.003 and 0.047 ± 0.002 
(Treated) at 2.4 and 4.8 and 7.2 Jig dose levels. 
The effect of testosterone administration on the activities of 
G6PD in intact and castrated male rats was compared in Figure 6. In 
castrated male rats, testosterone administration promoted about a 
60 % increase in the activities of G6PD from 0.02 ± 0.005 (CC.), to 
0.024 ± 0.003; 0.029 ± 0.0.003 and 0.042 ± 0.004 (Treated) in a 
dose-dependent manner, as compared to the intact treated rats in 
which the activity of G6PD in response to T administration produced 
minimal stimulation. 
The activities of G6PD in intact and castrated female rats 
following T administration is compared in Figure 7. G6PD activities 
Fig. 5 Effect of Testosterone Administration on the Activities of 
G6PD in Intact Male and Female Rats. Treated rats received 
2.4, 4.8 and 7.2 ng/day/rat pelleted testosterone by 
subcutaneous implantation and control rats received corn 
oil . Histograms represent mean specific activity of G6PD 
(Units/mg protein) ± SD of 3 rats in each treatment or 
control. Tissue preparation and enzyme assay conditions 
have been described under materials and methods. 
Treatments were not significantly different from the 
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Fig. 6 Effect of Testosterone Administration on the Activities of 
G6PD in Intact and Castrated Male Rats. Treated rats 
received 2.4, 4.8 and 7.2 pg/day/rat of pelleted 
testosterone by subcutaneous implantation and control rats 
received corn oil. Histograms represent mean specific 
activity of G6PD (Units/mg protein) ± SD of 3 rats in each 
treatment or control. Tissue preparation and enzyme assay 
conditions have been described under materials and 
methods. Treatments were not significantly different from 
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Fig. 7 Effect of Testosterone Administration on the Activities of 
G6PD in Intact and Castrated Female Rats. Treated rats 
received 2.4, 4.8 and 7.2 |ig/day/rat of pelleted 
testosterone by subcutaneous implantation and control rats 
received corn oil. Histograms represent mean specific 
activity of G6PD (Units/mg protein) ± SD of 3 rats in each 
treatment or control. Tissue preparation and enzyme assay 
conditions have been described under materials and 
methods. Treatments were not significantly different from 







































in response to T treatment decreased from 0.071 ± 0.003 (Cont.) to 
0.054 ± 0.004., 0.057 ± 0.003 and 0.047 ± 0.002 at 2.4, 4.8 and 7.2 
flg/day/rat dose rates in intact female rats. However, in castrated 
female rats, administration of T produced minimal increase in the 
activities of G6PD (0.043 ± 0.003.,CC vs 0.044 ± 0.002, 0.050 ± 
0.003 and 0.054 ± 0.001 at 2.4, 4.8 and 7.2 |ig/da//rat dose levels, 
respectively These increases were not significantly different from 
the control values. 
In Figure 8, the activities of G6PD in intact control (IC), 
castrated control (CC) and castrated (treated) male and female rats 
are compared following T administration. In intact rats, T treatment 
decreased the activities of G6PD by 17-23%.when compared with 
control values (0.026 ± 0.004 IC. vs 0.018 ± 0.003, 0.02 ± 0.003, and 
0.024 ± 0.004 (treated) and sex differences in the activity of the 
enzyme was not affected. Testosterone treatment increased the 
activity of G6PD in castrated rats from 0.02 ± 0.005 (CC.) to 0.024 ± 
0.003; 0.029 ± 0.0.003 and 0.042 ± 0.004 (treated) which 
corresponds to 2.4, 4.8 and 7.2 ug/day/rat dose rates. These 
increases were not statistically different from the control values. 
E Purification of G6PD from the Livers of Laving Hen and 
Immature Çhiçkgn (1 -12 wggk-Qld) 
Figures 9 and 10 represent the chromatographic profile of the 
purification of chicken liver G6PD on DEAE and CM celluloses, 
respectively. Tables 3, 4 and 5 represent the summary of 
purification of G6PD from the livers of 36 week-old laying hen, 12 
and 1 week-old immature chickens. The enzyme was purified about 
4000-fold relative to the cytosol and contained approximately 60 
Units/mg protein of enzyme activity. Figure 11 shows the 
electrophoretic profile of protein samples of the cytosol, ethanol, 
ammonium sulfate, DEAE, CM, and DEAE fractions , which show the 
extent of purification on 10 % PAGE. 
Fig. 8 Summary of Effects of Testosterone Treatment on the 
Activities of G6PD in Castrated Male and Female Rats. 
Histograms represent mean specific activity of G6PD 
(Units/mg protein) ± SD of 3 rats in each treatment or 
control. Tissue reparation and enzyme assay conditions 
have been described under materials and methods. 
Treatments were not significantly different from the 
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Fig. 9 A Representative Elution Profile of the Purification of 
Chicken Liver G6PD on DEAE Cellulose Chromatography. 
Approximately 2.24 units per mg protein were placed on 
the column and washed. The conditions for tissue 
preparation, enzyme assay, and the chromatographic 
purification of G6PD, unless otherwise stated are essentially 
the same as previously described under materials and 
methods. Protein from the elution fractions was 
determined by measuring the absorbance at 280 nm. 
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G6PD Activity (Abs. 340 nm) 
Fig. 10 A Representative Elution Profile of the Purification of 
Chicken Liver G6PD on CM Cellulose Chromatography. 
Approximately 16 units per mg protein were loaded on the 
column and washed. The conditions for tissue preparation, 
enzyme assay, and the chromatographic purification of 
G6PD , unless otherwise stated are essentially the same as 
described previously under materials and methods. 
Protein from the elution fractions was determined by 

















































TABLE 3. Summary of Purification of G6PD from Laying 
(36 week-old) Hen Liver 
Volume Total Act. Protein a Spc. Act. Fold 
Fraction (ml) (Units) (mg) (U/me prot) Purified 
Cytosol 375 92.0 5912 0.014 0 
Ethanol (25%) 360 80.7 3400 0.024 1.7 
(NH4)2S04.(25%) 360 75 1120 0.02 4.8 
DEAE Cellulose 230 61.4 110 0.056 40 
pH 5.5 Supt. 21 46 36 1.30 89 
CM Cellul.ose 190 32.3 1.3 23.1 1647 
DEAE Cellulose. 90 26.8 0.46 58.3 4161 
aProtein was determined according to the method of Bradford 
(1976) as described under materials and methods. Unless 
otherwise stated, all conditions of experiments are esssentally the 
same as previously described. 
TABLE 4 . Summary of Purification of G6PD from Immature 












Cytosol 208 138 5289 0.020 0 
Ethanol (25%) 232 92 3021 0.030 1.5 
(NH4)2S04.(25%) 25 5 85 636 0.134 6.7 
DEAE Cellulose. 124 65 29 2.24 112 
pH 5.5 Supt. ND b ND ND ND ND 
CM Cellulose. 177 48 2.2 21.8 091 
DEAE Cellulose. 85 36 0.6 60.0 3000 
aProtein was determined according to the method of Bradford 
(1976) as described under materials and methods. Unless 
otherwise stated, all conditions of experiments are esssentally the 
same as previously described, ^ND = Not Determined. 
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TABLE 5. Summary of Purification of G6PD from Immature 












Cytosol. 300 102.0 5878.0 0.017 0 
Ethanol (25%) 375 94.0 3470.0 0.027 2 
(NH4)2S04.(25%) 410 87.0 1112.0 0.078 5 
DEAE Cellulose 140 76.0 102.0 0.745 44 
pH 5.5 Supt. 20 46.0 21.0 2.19 129 
CM Cellululose 102 38.5 2.30 16.70 985 
DEAE Cellulose 70 30.8 0.54 57.04 3355 
aProtein was determined according to the method of Bradford 
(1976) as described under materials and methods. Unless 
otherwise stated, all conditions of experiments are esssentally the 
same as previously described. 
Fig. 11 An Electrophoretic Analysis of Protein Samples obtained 
during the purification of chicken Liver G6PD. on 10 % 
PAGE. 
Lane 1: Phosphorylase b (94 kD), BSA (66 kD), Ovalbumin 
(45 kD), Carbonic Anhydrase (31 kD), and Soybean 
Trypsin.Inhibitor (22 kD) as molecular weight markers. 
Lane 2 : L.mesenteroides G6PD. Lane 3 : Cytosol, lane 4: 
Ethanol-treated, lane 5 :(NH4)2S04-treated. lane 6 : DEAE 
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F: Estimation of Molecular Weight 
Gel filtration on G-200 was used to estimate the molecular 
weight of G6PD. The molecular weight was estimated from the plot 
of log molecular weight of the markers versus the heights of the 
elution volumes (Fig. 12). The chromatography of the enzyme gave 
an active enzyme with molecular weight estimated at 130,000. 
G: Kinetic Behavior of the Purified enzyme 
1. Specificities for Substrate 
The specificity of the enzyme for glucose 6-phosphate (G6P), 
glucose l-phosphate(GlP) and glucose was determined, using 
various concentrations of the sugars in the presence of the enzyme 
and its cofactor. The specificity of G6P for the enzyme was greater 
(km = 0.1 mM) (Fig. 13) in contrast to G1P (30 mM) and glucose (60 
mM). 
2. Specificity for Cofactor 
The specificity of various nucleotides for the enzyme was also 
determined, using various concentrations of NADP, NAD and FAD. 
NADP (km 20 j0.M) was highly specific for the enzyme (Fig.14) 
relative to NAD (400 JlM.) and FAD (600 (J.M). 
3 Effect of Monovalent Cations on the Activity of G6PD 
Monovalent cations (KC1, NaCl and NH4CI) minimally 
stimulated the activity of G6PD (Table 6). At a concentration of 5-20 
mM, the increase in the activity of G6PD was approximately 8 %. 
These increases were essentially the same as in control, except for 
ammonium chloride which was significantly different (P<0.05) at 20 
mM, relative to the control. Maximal stimulation, of G6PD activity 
occurred at 10 -20 mM. 
Fig. 12 Estimation of the Molecular Weight, of G6PD on Gel 
filtration, G200. GO = Glucose oxidase (150 kD), HK = 
Hexokinase (100 kD), BSA = Bovine Serum Albumin (68 Kd) 
and MO = Myoglobin (17 kD) were used as markers. Blue 
dextran was used to mark the void volume and the known 
molecular weights were plotted against the heights of the 
elution volumes. The conditions for enzyme assay, and gel 
filtration, unless otherwise stated are essentially the same 
as described previously under materials and methods. 
Protein from the elution fraction was determined by 










Fig. 13 Lineweaver-Burk Plot of the Purified G6PD Activity at 
Varying Concentrations of Glucose 6-phosphate (G6P). 
Each point represents the mean activity of G6PD in 
triplicate assay. The conditions for enzyme assay, unless 
otherwise stated are essentially the same as described 
previously under materials and methods. 
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Fig. 14 Lineweaver-Burk plot of the Purified G6PD activity at 
Varying Concentrations of Nicotinamide Adenine 
Dinucleotide Phosphate (NADP). Each point represents the 
mean activity of G6PD in triplicate assay. The conditions 
for enzyme assay, unless otherwise stated are essentially 




Table 6. Effects of Monovalent Cations on the Activity of Glucose 
6-phosphate Dehydrogenase 
Cone. G6PD Relative Activity ( % ) 
(uM) KQ NaCl NH4CI 
0 100 100 100 
5 105 105 113 
10 1 11 107 123 
20 125 119 144 
40 113 106 119 
80 106 102 109 
100 101 101 103 
Assay buffers were devoid of divalent cations. Enzyme solution was 
dialyzed in 50 mM Tris buffer, pH 8.5. About 20 p.1 of enzyme 
solution containing 30 p.g of protein was used per assay. Unless 
otherwise stated, enzyme assay conditions are essentially the same as 
described under materials and methods. 
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4 Effect of Divalent Cations on the Activity of G6PD 
The effect of divalent cations on the activity of G6PD was 
determined. Table 7 shows that the chloride ions of cadmium, 
manganese, nickel and zinc stimulated the activity of chicken liver 
G6PD activity at a minimum concentration of 2.5 (J.M relative to the 
control or zero. The optimum effective concentration occurred 
between 10 and 20 |i.M. At higher concentrations these metals were 
inhibitory. These changes in the activity of G6PD in response to 
stimulation by divalent cations were not statistically different from 
the control except for the chloride ions of manganese (20-40 |lM ) 
and magnesium (5-40 |lM), which were statistically different 
(P<0.05) as compared to the control. 
5. Effect of pH on the Activity of G6PD 
The effect of changing the pH of the assay mixture was 
studied. The activity of G6PD revealed two pH optima (Figure 15). 
At the pH optimum of 6.0 the activity of G6PD (Units ± SD ) was 
0.018 ± 0.001 and the activity at 8.5 was 0.034 ± 0.002. This 
observation was essentially the same when the 110,000 x_& SNF was 
used » 
6. Stability of G6PD 
a. Ambient temperature: The purified enzyme was very unstable 
without the protection of NADP. Figure 16A shows the stabilization 
of G6PD by NADP expressed as percent remaining activity monitored 
over time. The activity of G6PD in the presence of 0.1 mM NADP 
remained fairly stable throughout the entire period. However, in 
the control sample which lacks the protection of NADP, the activity 
of G6PD decreased 15 and 30% during the first 2 hrs, respectively 
and about 20% of the total activity remained at about 4 hours. 
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G6PD Relative Activity ( % ) 
MnCl2 NiCl2 MgCl2 ZnCl2 
0 100 100 100 100 100 
2.5 104 110 101 106 115 
5.0 106 117 104 107 122 
10.0 108 122 106 115 131 
20.0 111 133 109 124 134 
40.0 106 131 102 132 119 
80.0 100 124 100 106 109 
100.0 95 90 93 96 95 
Assay buffers were devoid of divalent cations. Enzyme solution was 
dialyzed in 50 mM Tris buffer, pH 8.5. About 20 pi of enzyme 
solution containing 30 |ig of protein was used per assay. Unless 
otherwise stated, enzyme assay conditions are essentially the same as 
described under materials and methods. 
Fig. 15 The Effect of pH on the Activity of G6PD. Each point is a 
mean of G6PD activity (Units/min) ± SD. Assays were 
performed in triplicate. The assay conditions are 
essentially the same as described under materials and 
methods except that buffers of varying pH (5.0 - 10.5) 
















Fig.lôA Stability of Purified Chicken Liver G6PD at Ambient 
Temperature. G6PD (40 ug/ml) was incubated in Tris-HCl, 
pH 8.5 in the presence of 0.1 mM NADP. Points represent 
mean specific activity of G6PD ± SD. The activity (% 
Activity) was determined in triplicate spectro- 
photometrically. The conditions for enzyme assay, unless 
otherwise stated are essentially the same as described 






Figure 16B shows the effect of heat on the stability of the 
enzyme. The enzyme solution heated at varying temperatures for 5 
min in the presence of 0.1 mM NADP retained about 83 and 60 % of 
its activity at 47 and 52 C, respectively, and only about 20 % of the 
activity remained at 62 C. In the control sample, the activity 
retained was about 60 and 12 % at 47 and 52 C. 
c Effect of NADP. G6P and F6P 
The stabilization of G6PD activity by NADP appears to be 
concentration-dependent. At 50 C, the enzyme solution containing 
0.1 mM NADP had lost about 50 and 62 % of its activity at 10 and 20 
mins of heating, respectively. In contrast , the fraction containing 
0.3 mM NADP lost about 30 and 42 % of its activity at the same 
period (Figure 16C). In addition to NADP, the activity of G6PD was 
protected against thermal inactivation, when the enzyme was 
incubated in the presence of G6P 0.3 mM or 0.5 mM F6P (Figure 
16D). 
H: Effect of Age and Sex on G6PD Activity 
Age : The G6PD activities from immature chicken (1 and 12 
week-old) and adult male and female chicken (36 week-old) were 
compared (Table 8) The specific activity (units/mg protein) of G6PD 
from 12 and 36 week-old female chicken was 50 % higher (0.022 ± 
0.003 ) than those of the 1 week-old chicken. (0.012 ± 0.002) and 
adult male chicken (0.010 ± 0.001). 
Sex.: The sex difference in the activity (units/mg protein) of 
G6PD between the adult male and female chicken (0.01 ± 0.001, 
male; vs 0.019 ± 0.003, female) was significant (P<0.01) as 












Fig. 16C Effects of NADP Concentration on the Protection of Purified 
Chicken Liver G6PD Against Thermal Inactivation. The 
enzyme (40 ng/ml) in Tris-HCl, pH 8.5 was heated for 5 
mins in the presence of 0.1 and 0.3 mM NADP. Points 
represent mean specific activity of G6PD ± SD. The activity 
expressed as (% Activity) was determined in triplicate 
spectrophotometrically. The conditions for enzyme assay, 
unless otherwise stated are essentially the same as 














Fig. 16D Effects of G6P and F6P on the Stabilization of Purified 
Chicken Liver G6PD Against Thermal Inactivation. The 
enzyme (40 ug/ml) was heated for 5 min in Tris-HCl, pH 
8.5 in the presence of 0.3 mM NADP. Points represent mean 
specific activity of G6PD ± SD. The activity expressed as 
was determined in triplicate spectrophotometrically. The 
conditions for enzyme assay, unless otherwise stated are 
essentially the same as described previously under 
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TABLE 8. The Effect of Age and Sex Difference on the Activity 
of Glucose 6-Phosphate Dehydrogeanse 
No. of G6PD Activity a 
Sex Animals Age (Units/mg protein ± SD) 
Female 30 1 week-old 0.010 ± 0.002 
Female 20 12 week-old 0.022 ± 0.003* P<.01 
Female 30 36 week-old 0.019 ± 0.003* P<.01 
Male 12 36 week-old 0.010 ± 0.001 
a Values are mean ± SD. Enzyme activity was determined in 
triplicate assays. Unless otherwise stated, enzyme assay 
conditions are essentially the same as described under materials 
and methods. * Statistically significant relative to the values of 
the control animals (1 week-old). 
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I: G6PD Isozymes and Molecular Weight 
Figs. 17A, 18A and 19A represent G6PD isozymes bands from 
the livers of laying hen (36 wk-old), and the immature chicken (12 
and 1 week -old), respectively on 5.5% non-denatured PAGE. Fig. 
17A revealed three isozyme bands of G6PD which showed a deep 
stain intensity for bands A ( slowest moving band) and light for 
band C (fast moving band). In Figs. 18A and 19A, three isozymes 
were also observed but stain intensity was light in band A and deep 
in band C. Figs. 17B, 18B and 19B show a densitometer gel scan 
profile of G6PD isozymes which correlate relative peak heights to 
stain intensity. Table 9 shows a densitometer analysis of the 
percent composition of protein in each isozyme band. The analysis 
revealed a relative protein content of 57% in band A, while bands B 
and C contained 27 and 16 %, respectively in the laying hen. In the 
developing chicken (1 and 12 week-old ), the protein content of 
isozyme bands were different. The composition of band C ranged 
from 54% (1 week-old) to 66% (12 week-old). Electrophoretic 
analysis of the purified G6PD and the isozymes from 36, 12 and 1 
week old chicken (Fig. 20 and 21) on 10 % SDS-PAGE revealed single 
subunit bands and the molecular weights were estimated at 65,000 
Fig.l7A An Electrophoretic Profile of Liver G6PD Isozyme Bands 
from Adult Laying Hen (36 week-old chicken) on 5.5% 
Polyacrylamide Gel (non-denaturing gel). Liver cytosol 
(0.02 Units/mg protein) was diluted 1: 15 with 40% sucrose 
in 0.1 mM NADP. The conditions for tissue preparation, and 
electrophoresis (non-denature gel), unless otherwise stated 
are essentially the same as described previously under 
materials and methods. 
Bands 
Fig.l8A An Electrophoretic Profile of Liver G6PD Isozyme Bands 
from Immature Female Chicken (12 week-old) on 5.5% 
Polyacrylamide Gel (non-denaturing gel). Liver cytosol 
(0.02 Units/mg protein) was diluted 1: 15 with 40% sucrose 
in 0.1 mM NADP. The conditions for tissue preparation, and 
gel electrophoresis (non-denatured gel) unless otherwise 
stated are essentially the same as described previously 








Fig.l7B Laser Densitometer Scan of Liver G6PD Isozymes Peaks 
Profile of Adult Laying Hen (36 week-old ) on 5.5% PAGE 
(non-denaturing gel.). The x-axis represents the length 





Fig. 18B Laser Densitometer Scan of Liver G6PD Isozymes Peaks 
Profile of Immature Female Chicken (12 week-old) on 5.5% 
PAGE (non-denaturing gel). The x-axis represents the 
length (mm) of gel scan. The y-axis represents the 













Fig. 19B Laser Densitometer Scan of Liver G6PD Isozymes Peaks 
Profiles from Immature Female Chicken (1 week-old) on 
5.5% PAGE (non-denaturing gel). The x-axis represents the 
length (mm) of gel scan. The y-axis represents the 
























1 (F) A 4.0 
B 33.0 65,000 
C 54.0 
12 (F) A 9.0 
B 25.0 65,000 
C 66.0 
36 (F) A 58.0 
B 27.0 65,000 
C 16.0 
a % Composition (relative protein content) of isozyme bands was 
derived from laser densitomer analysis (abs. 633 nm). 
^Isozyme was repurified on preparative electrophoresis and used 
for SDS-PAGE. 
Fig. 20 An Electrophoretic Analysis of Partially Purified G6PD 
Isozymes from Chicken Livers on 10% SDS. Lanes 1 = 
Phosphorylase b (94 kD), BSA.(66 kD), Ovalbumin (45 
kD), Carbonic Anhydrase (31 kD) and Soybean Trypsin 
Inhibitor. (22 Kd) as markers. Lanes 2, 3 and 4 = Chicken 
liver G6PD from 36, 12 and 1 week-old respectively. The 
conditions for tissue preparation,and SDS-PAGE unless 
otherwise stated are essentially the same as described 
previously under materials and methods. 
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Fig. 21 An Electrophoretic Analysis of Purified G6PD from Chicken 
Liver on 10% SDS.. Lanes 1 = Phosphorylase b (94 kD), 
BSA.(66 KD), Ovalbumin (45 kD), Carbonic Anhydrase (31 
KD) and Soybean Trypsin Inhibitor. (22 kD) as markers. 
Lane 2 = L_. mesenteroides (G6PD). Lanes 3, 4 and 5 = 
Chicken liver G6PD from 36, 12 and 1 week-old 
respectively. The conditions for tissue preparation, and 
SDS-PAGE unless otherwise stated are essentially the same 




Pharmacological doses of either estrogen or testosterone have 
been used in the past to demonstrate stimulation or inhibition of 
G6PD activity (Higgins and Yao, 1959; Roux etal. 1972; Berdanier, 
1981). The present investigation was conducted to determine 
whether low sustained doses of these steroids will stimulate or 
inhibit significantly the activity of G6PD. The data obtained from 
the present study showed that physiological doses of these steroids 
stimulated the activity of G6PD. 
In the present study, E2 or T-induced decrease in food intake 
was not apparent. Within each group set, food consumption was not 
different between E2-exposed animals and their controls. The 
major controlling factor in food intake was the event of castration. 
Male rats consumed more food than their female counterparts 
across group sets. Thus castration decreased food consumption in 
all animals, male and female with no recovery or further decrease 
upon estradiol or testosterone exposure. Consequently, food intake, 
body and liver weights were not influenced by either treatment. 
These effects of castration, estradiol and testosterone treatment 
held true for liver fresh weights though a slight reduction in liver 
weights resulted in intact male rats upon estrogen than 
testosterone exposure. 
In control rats, castration decreased the activity of G6PD by 
25-28% but did not eliminate the sex difference. These observations 
are in agreement with earlier studies (Hilf etal. 1972; Ozols and 
Hilf, 1973) which showed decreased G6PD activity in castrated male 
and female rats. The decrease in G6PD activity may be associated 
with the loss of circulating E2 or T (Guyton, 1968) present in low 
amounts (5-10 pg/ml) in normal rats (Smith etal., 1975), as a result 
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of the removal of the ovarian or testicular receptors. However, 
since the sex difference was not eliminated, the difference in the 
activity of G6PD between normal male and female rats may have 
been predetermined early in life, since sex differences were not 
found in new born rats, that have an enzyme activity about 75% 
that of the adult male rat (Huggins and Yao, 1959). 
In E2-supplemented castrates, the activity of G6PD in 
response to estrogen treatment increased markedly, especially in 
castrated male rats. Enhancement in the activity of G6PD may be 
due to increased sensitivity of receptors in the liver or adrenal 
glands. This enhanced stimulation resulted in the 6-fold increase 
and the loss of sex difference in G6PD activity in estrogen- 
supplemented male rats (Fig.4). Estrogen administration was 
reported to increase in the activity of G6PD in hepatocyte cultures 
(Hansen and Jungerman, 1987). The induction in hepatic G6PD 
activity of male rats was also observed by Huggins and Yao (1959), 
Berdanier (1981) and in the uteri of female rats by Scott and Lisi 
(1960) and (Hilf et ad. 1972). Although pharmacological doses were 
used in previous studies to demonstrate increases in the activity of 
G6PD, these studies supported the present data which utilized 
physiological doses to demonstrate similar increases in the activity 
of G6PD. In addition to the sensitivity of these receptors, the 
increase in the activity of G6PD in T-supplemented male and female 
rats, was also due to the peripheral conversion of testosterone to 
estrogen by an aromatase enzyme. In the present study, T 
administration caused the activity of G6PD to increase by 65 %. in 
castrated male and female rats. Consequently, the observed 
increase in the activity of G6PD as a result of T supplementation is 
in agreement with previous studies (Longscope, C. 1971, Longscope 
et al., 1978, Knudsen and Max,1980) in which the conversion of T to 
E2 had been demonstrated in many tissues including rats and 
humans. 
Dose-related increases in the activity of G6PD were 
demonstrated in androgen-dependent male accessory organs of rats 
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following T administration (Lerner el ai., 1968; Sholl and 
Leathern,1973; Ozol and Hilf, 1973). Roux et ai. (1975) used 
pharmacological dose of T and concluded that testosterone 
depressed G6PD activity. In the present study, a physiological dose 
of T was found to stimulate the activity of G6PD. These data do not 
contradict the earlier studies (Huggins and Yao, 1959; Roux el ai., 
1975; Hansen and Jungermann, 1987) which showed that 
testosterone inhibited the activity of G6PD, since physiologically 
relevant doses were used in the present study. These increases in 
G6PD activities following T exposure were not significantly different 
from the control probably because of the limited number of 
observations per treatment (N=3) used in this study. Since 
testosterone is aromatized to estradiol in the tissues, the observed 
enhancements in the activity of G6PD following T administration 
may reflect an indirect effect of E2. Additional studies may be 
needed to demonstrate the effect of non-aromatizable 
dihydrotestosterone (DHT), the most active form of testosterone. 
The increases in the activity of G6PD as a result of E2 or T treatment 
may be associated with de novo synthesis of new enzymes (Baldwin 
and Milligan, 1966) or a modification of preexisting enzymes. In the 
present study, the response in the activity of G6PD as a result of the 
steroid hormone treatment was markedly enhanced, therefore, 
further attempts were not made to investigate whether the 
increases were associated with protein synthesis, DNA or a simple 
modification. 
The pelletized steroid hormones used in this study were 
designed for a slow release over 21 days. Three doses of 50, 100 
and 150 pg were implanted subcutaneously, with an effective 
release rate of 2.4, 4.8 and 7.2 pg/day, respectively. In the present 
study, the low dose of E2 (2.4 pg/day) produced a higher 
stimulation in the activity of G6PD than 4.8 and 7.2 pg/day 
respectively. Therefore, it is reasonable to assume that the initial 
dose was the effective dose (Fig. 4). Serum E2/ T levels were higher 
(6-13 %) in rats that received the higher dose (7.2 pg/day) while 
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the low to medium E2/ T dose levels were identical to the initial 
dose (2.4|ig/day). Time-course experiments showed that the onset 
of G6PD activity at 0, 4, 8 and 12 days of exposure followed a dose- 
response kinetics. These studies, which were also similar for 
testosterone therefore suggested that the hormones were 
effectively delivered to target tissues and the activity of G6PD was a 
result of E2/ T stimulation. 
Throughout this study, the administration of estrogen or 
testosterone was shown to stimulate increases in G6PD activity in 
male and female rats. These data are in agreement with the studies 
of Hansen and Jungermann (1987) in rat hepatocyte culture, but did 
not support the finding of Berdanier (1981), Higgins and Yao (1959) 
who observed decreased activity of this enzyme in castrated female 
rats supplemented with E2. The apparent differences in the 
observed data may be due to varying rates of E2 exposure, food 
intake or age of animals, all of which are known to influence the 
activity of G6PD enzyme. The observed increases in the activity of 
G6PD following testosterone administration did not contradict 
previous studies ((Higgins and Yao, 1959; Roux etal. 1972; Hansen 
and Jungerman, 1987). In these studies, pharmacological doses of 
testosterone were used to elicit stimulation of G6PD activity in 
contrast to the present study which utilized physiological doses. 
Nevertheless, the experiment demonstrated that T is stimulatory at 
physiological doses.- 
The purified G6PD was specific for G6P (Km = 100 pM) as 
substrate and for NADP (Km = 20 pM) as cofactor. These Km values 
are comparable to values previously reported (0.015-0.5 mM G6P), 
and 2.5-150 pM (NADP) in bacterial tissues , 0.012-0.098 mM (G6P) 
and 2.0-69 pM (NADP) in mammalian tissues (Levy, 1961). The 
enzyme did not show any specificity for G1P and glucose (Km = 30 
and 60 mM respectively) as substrates; NAD or FAD (Km = 0.4 and 
0.6 mM) as cofactors. Levy ( 1961), showed that some mammalian 
G6PD can catalyze the reduction of NAD only at high concentrations. 
Therefore, there is also the possibility that those mammalian G6PD's 
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that reduce NAD to NADH probably have isozymes with dual 
nucleotide specificity. L. mesenteroides. a bacterial G6PD is one of 
such enzymes that is known to catalyze the reduction of both NADP 
and NAD. The enzyme is stimulated by both movalent and divalent 
cations, although in some studies, bacterial G6PD's have been shown 
to be inhibited by cadmium, nickel, manganese and zinc (Niehaus 
and Dilts, 1984). The observed pH optima is in agreement with 
previous report of Koby and Roy (1976) who demonstrated the 
involvement of a histidine (acid range) and a lysine (basic range) 
residues at the catalytic site of S., carlsbergensis G6PD The ability of 
NADP to stabilize G6PD has also been demonstrated by other 
investigators (Chung and Langdon, 1963; Hersey etal.1963; Lee et 
aL1979). These studies also support the current observations that 
NADP protected the enzyme against thermal inactivation., although 
G6P, F6P at higher concentration also protected the enzyme activity. 
Sex differences in the activity of rat liver G6PD had been 
reported by several investigators (Glock and McLean , 1953; 1956., 
Slater et. ad., 1964; Roux etaj_.1972; Winston and Reitz, 1979; 
Berdenier, 1981; Hansen and Jungermann, 1987; Ibim etal., 1988, 
1989). In the present study, sex differences in the activity of 
chicken liver G6PD were also observed. In the 12 week-old chicken, 
the level of G6PD activity was similar to the level found in the 
adult hen. The increased level of G6PD activity in the 12 week-old 
may be due to intracellular changes, associated with growth and 
development relative to the 1 week-old. However, in the adult, the 
higher activity of G6PD may be explained on the basis of estrogen 
stimulation. Similarly, in contrast to laying hen , the lower G6PD 
activity in the adult male chicken may be associated with a 
repressed gene activity or the predominance of testosterone 
production. 
The molecular identity of the enzyme was further assessed by 
estimating the molecular weight of the enzyme in the adult as well 
as in the immature chicken. The results from this study indicated 
that the chicken liver G6PD exists as a dimer with molecular wt .as 
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130.000 and a monomer with molecular weight, of 65,000. This 
information is comparable to the molecular weights previously 
reported for some mammalian G6PD which ranged from 100,000- 
120.000 and possessed similar characteristics (Olive and Levy, 
1971; Nevaldine and Levy, 1974; Shreve and Levy, 1977). The 
enzyme also revealed three isozymes with subunit molecular weight 
of 65,000 on SDS-PAGE. Therefore, these data further confirmed 
previous reports (Hilf etaL, 1973; 1975; 1976) of the presence of 
three molecular forms of G6PD in the mammary glands of Balb/c 
mice, with varying sizes and proportions during pregnancy and 
lactation. The isozyme pattern of G6PD in immature (1 and 12 
week-old) are similar but differed in proportions and sizes in 
contrast to those of the adult chicken. These developmental 
changes may be related to the lack of hormonal activities in the 
immature chicken in contrast to the high level of circulating 
estrogen in the laying hen. Although the pattern of isozyme 
changed between the 12 week-old and the adult chicken, the exact 
time course at which hormones influenced these changes was not 
determined in this study. However, Hori and Matsui (1967) 
identified six molecular forms of G6PD in the rat and observed that 
isozyme D was enzymatically active in female but absent in new 
born rats. Hersey et al, (1966) and Richards and Hilf (1971; 1972;), 
observed three isozymes (G6PD-1, G6PD-2 and G6PD-3) in the 
mammary breast of pregnant and lactating rats and concluded that 
only one G6PD isozyme was responsive to estrogen treatment. 
The present study demonstrated that the administration of 
physiological doses of estradiol (E2) to rats significantly increased 
the activity of hepatic G6PD in castrated male and female rats. In 
similar studies, testosterone (T) in low doses minimally enhanced 
the activity of G6PD in castrated male and female rats. These data 
seem to contradict previous studies, which used high dose of 
testosterone used to demonstrate the inhibition of G6PD activity. 
The enzyme activity was low in the immature (1-12 week-old) 
female chicken, perhaps due to low level of estrogen activities but 
81 
increased at the time of laying under the influence of circulating 
estradiol. The isozymes patterns were also similar in the immature 
(1-12 weeks) and the adult male and female chicken (36 week-old), 
although their proportions and sizes in the immature female and 
the mature male chicken may be different. The altered 
composition, sizes and patterns may be due to the influence of 
estradiol. These differences in isozyme patterns may be related to 
maturational as well as hormonal (estradiol and testosterone) 
influence. However, electrophoretic analysis revealed that the 
purified enzyme and the isozyme have similar subunit molecular 
weight (65kD) on SDS-PAGE and the molecular characteristic and 
properties of the enzyme appear to be similar to other mammalian 
enzymes. 
CHAPTER VI 
SUMMARY AND CONCLUSION 
This investigation examined the effects of sex steroid 
hormones (estradiol and testosterone), on the development and 
differential expression of G6PD. Castrated male and female as well 
as intact rats were exposed to graded doses of estradiol or 
testosterone in separate studies. The enzyme was purified from 
laying chicken liver. The molecular properties as well as isozymes 
and subunits were compared to G6PD from immature chicken (1-12 
week-old). The results were as follows: 
(1) G6PD activity was 3-fold higher in normal adult female rats 
than in male rats. 
(2) Low doses of estradiol (E2) (2.4, 4.8 and 7.2 ug/day) 
increased the activity of G6PD, however, the initial dose 
promoted a 6-fold increase in the activity of G6PD in 
castrated males and over 2-fold in female castrates as well 
as in intact rats . 
(3) Estradiol stimulation of G6PD activity appears to be more 
effective in castrated males than female rats . 
(4) Sex differences in the activity of G6PD disappeared after 
treatment with E2. 
(5) Estradiol administration did not significantly alter weight 
gain, liver wt and food intake patterns of the rats during 
treatment. 
(6) Testosterone ( T ) administration did not alter the sex 
differences in the activity of rat liver G6PD. 
(7) T administration (2.4, 4.8 and 7.2 ug/day/rat) did not 
produce significant increase in the activity of G6PD in 
castrated males and female rats. 
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(8) The activity of chicken liver G6PD in the laying hen was 
nearly two-fold greater than that in the adult male chicken. 
(9) G6PD was purified 3000-4000 fold and the specific activity 
was about 60 Units/mg protein. 
(10) The purified enzyme was specific for G6P (Km 0.1 mM) and 
the NADP (Km 20 |iM ), respectively. 
(11) NAD and FAD did not affect the catalytic activity of G6PD; 
(12) G1P and glucose are not suitable for the enzyme but at high 
concentration, G6PD can catalyze their oxidation. 
(13) Monovalent (NaCl, KC1, NH4CI) and divalent cations (CdCl2, 
NiCl2, MgCl2, MnCl2 and ZnCl2) stimulated the activity of the 
enzyme. 
(14) The enzyme revealed two pH optima. NADP, G6P and F6P 
were protective of the enzyme. 
(15) The molecular wt of the enzyme was estimated at 130,000 
as a dimer and 65,000, as the inactive monomer. 
(16) Three molecular forms of G6PD were detected from the 
livers of immature (1, 12 week-old females) and adult (36 
week-old females) as well as 36 week-old male chicken on 
5.5 % PAG. 
(17) The composition and sizes of the isozymes from the 
immature and adult male chickens were similar but 
different relative to the isozymes patterns of the adult 
layers. These differences may be due to maturational and 
hormonal changes in development. The subunit molecular 
weights of these isozymes were similar (65,000). 
(18) The purified enzyme on 10% SDS-PAGE also revealed a 
subunit band of 65,000. 
This investigation concluded that sex steroids (estradiol and 
testosterone) but particularly estradiol in low doses, markedly 
enhanced the activity of G6PD. These hormones appear to be 
responsible for the sex difference in rat and in the chicken, and may 
play a role in the compositional differences of G6PD isozymes during 
the maturation of the animal. 
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